The roles of GTPase-activating proteins in regulated cell death and tumor immunity

J Hematol Oncol. 2021 Oct 18;14(1):171. doi: 10.1186/s13045-021-01184-1.

Abstract

GTPase-activating protein (GAP) is a negative regulator of GTPase protein that is thought to promote the conversion of the active GTPase-GTP form to the GTPase-GDP form. Based on its ability to regulate GTPase proteins and other domains, GAPs are directly or indirectly involved in various cell requirement processes. We reviewed the existing evidence of GAPs regulating regulated cell death (RCD), mainly apoptosis and autophagy, as well as some novel RCDs, with particular attention to their association in diseases, especially cancer. We also considered that GAPs could affect tumor immunity and attempted to link GAPs, RCD and tumor immunity. A deeper understanding of the GAPs for regulating these processes could lead to the discovery of new therapeutic targets to avoid pathologic cell loss or to mediate cancer cell death.

Keywords: GTPase-activating proteins; Regulated cell death; Tumor immunity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • GTP Phosphohydrolases / immunology
  • GTPase-Activating Proteins / immunology*
  • Guanosine Triphosphate / immunology
  • Humans
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Regulated Cell Death*

Substances

  • GTPase-Activating Proteins
  • Guanosine Triphosphate
  • GTP Phosphohydrolases